Product/Service
Metabolic Disorders & Endocrine Clinical Trials
Source: ICON
Running global studies in endocrine and metabolic disorders is a core competency within ICON. Over the last five years, ICON teams have conducted 376 projects, representing more than 160,000 patients, and 18,700 sites.
Click Here To Download:
•Brochure: Drug Development For Metabolic Disorders
•Brochure: Diabetes Clinical Trials
•Brochure: Drug Development For Metabolic Disorders
•Brochure: Diabetes Clinical Trials
•Brochure: Drug Development For Metabolic Disorders
•Brochure: Diabetes Clinical Trials
Running global studies in endocrine and metabolic disorders is a core competency within ICON. Over the last five years, ICON teams have conducted 376 projects, representing more than 160,000 patients, and 18,700 sites.
ICON has conducted diabetes trials in all global regions and has particular experience in running studies in emerging regions such as Eastern Europe, India and South America where there are large pools of treatment naïve patients. ICON has a network of offices in these regions and has developed strong relationships with investigator sites to ensure high rates of patient enrolment and retention.
Click Here To Download:•Brochure: Drug Development For Metabolic Disorders
•Brochure: Diabetes Clinical Trials
